These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 3121772)

  • 1. Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer.
    Grøndahl-Hansen J; Agerlin N; Munkholm-Larsen P; Bach F; Nielsen LS; Dombernowsky P; Danø K
    J Lab Clin Med; 1988 Jan; 111(1):42-51. PubMed ID: 3121772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of urokinase-type plasminogen activator (u-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies.
    Darras V; Thienpont M; Stump DC; Collen D
    Thromb Haemost; 1986 Dec; 56(3):411-4. PubMed ID: 3105111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An enzyme-linked immunosorbent assay for urokinase-type plasminogen activator (u-PA) and mutants and chimeras containing the serine protease domain of u-PA.
    Declerck PJ; Van Keer L; Verstreken M; Collen D
    Thromb Haemost; 1992 Jan; 67(1):95-100. PubMed ID: 1377417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its proenzyme using a combination of monoclonal and polyclonal antibodies.
    Nielsen LS; Grøndahl-Hansen J; Andreasen PA; Skriver L; Zeuthen J; Danø K
    J Immunoassay; 1986; 7(3):209-28. PubMed ID: 3091639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of free tissue-type and free urokinase-type plasminogen activators in biological fluids by a solid-phase immunoassay.
    Kuo BS; Bjornsson TD
    Anal Biochem; 1993 Feb; 209(1):70-8. PubMed ID: 8465964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA.
    Holvoet P; Cleemput H; Collen D
    Thromb Haemost; 1985 Oct; 54(3):684-7. PubMed ID: 3937265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of fibrinolytic capacity in plasma during thrombolytic therapy with single (scu-PA) or two-chain urokinase type plasminogen activator (tcu-PA) by a combined assay system for urokinase type plasminogen activator antigen and function.
    Wojta J; Binder BR; Huber K; Hoover RL
    Thromb Haemost; 1989 Apr; 61(2):289-93. PubMed ID: 2501899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice.
    Declerck PJ; Verstreken M; Collen D
    Thromb Haemost; 1995 Nov; 74(5):1305-9. PubMed ID: 8607114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A specific immunologic assay for functional plasminogen activator inhibitor 1 in plasma--standardized measurements of the inhibitor and related parameters in patients with venous thromboembolic disease.
    Philips M; Juul AG; Selmer J; Lind B; Thorsen S
    Thromb Haemost; 1992 Nov; 68(5):486-94. PubMed ID: 1455392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis.
    Kim SJ; Shiba E; Kobayashi T; Yayoi E; Furukawa J; Takatsuka Y; Shin E; Koyama H; Inaji H; Takai S
    Clin Cancer Res; 1998 Jan; 4(1):177-82. PubMed ID: 9516968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive solid-phase immunosorbent assay for tissue-type plasminogen activator activity in plasma using trinitrobenzoylated poly-D-lysine as a stimulator for plasminogen activation.
    Petersen LC; Handest P; Brender J; Selmer J; Jørgensen M; Thorsen S
    Thromb Haemost; 1987 Apr; 57(2):205-11. PubMed ID: 3110997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical exercise induces enhancement of urokinase-type plasminogen activator (u-PA) levels in plasma.
    Dooijewaard G; de Boer A; Turion PN; Cohen AF; Breimer DD; Kluft C
    Thromb Haemost; 1991 Jan; 65(1):82-6. PubMed ID: 1902597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assay and detection methods for urokinase-type plasminogen activator and its related-factors].
    Kimura K; Endo Y; Sasaki T
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):1009-17. PubMed ID: 10396332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contact-system dependent plasminogen activator from human plasma: identification and characterization.
    Binnema DJ; Dooijewaard G; van Iersel JJ; Turion PN; Kluft C
    Thromb Haemost; 1990 Nov; 64(3):390-7. PubMed ID: 2128968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma.
    Hofmann R; Lehmer A; Buresch M; Hartung R; Ulm K
    Cancer; 1996 Aug; 78(3):487-92. PubMed ID: 8697395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
    Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; Brünner N; Sweep CG; Duffy MJ
    Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis.
    Tran-Thang C; Fasel-Felley J; Pralong G; Hofstetter JR; Bachmann F; Kruithof EK
    Thromb Haemost; 1989 Sep; 62(2):651-3. PubMed ID: 2510345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix.
    Grøndahl-Hansen J; Kirkeby LT; Ralfkiaer E; Kristensen P; Lund LR; Danø K
    Am J Pathol; 1989 Oct; 135(4):631-6. PubMed ID: 2508479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma levels of urokinase-type plasminogen activator with endometrial and cervical cancer.
    Koelbl H; Kirchheimer JC; Tatra G; Christ G; Binder BR
    Obstet Gynecol; 1988 Aug; 72(2):252-6. PubMed ID: 3134631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.